Did the FDA Just Put Lorillard Inc. (LO) Earnings at Risk?

In the Lorillard earnings report, don’t expect to see any immediate damage from the FDA evaluation, but pay attention to find out how the company plans to respond. Even though a final decision could be years away, the stakes are extremely high for Lorillard if it wants to protect the industry niche that it has worked so hard to carve out for itself.

The article Did the FDA Just Put Lorillard Earnings at Risk? originally appeared on Fool.com and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned, and neither does The Motley Fool. You can follow Dan on Twitter @DanCaplinger.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.